{"url_path":"/sec/capr/8-k/2026-07-14/item-2-03","section_key":"item-2-03","section_title":"Item 2.03 ****Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-14","source_url":"https://www.sec.gov/Archives/edgar/data/1133869/0001104659-26-083559-index.html","accession_number":"0001104659-26-083559","cik":"0001133869","ticker":"CAPR","issuer_name":"CAPRICOR THERAPEUTICS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1133869/0001104659-26-083559-index.html","primary_entity_key":"0001133869","primary_entity_name":"CAPRICOR THERAPEUTICS, INC."},"word_count":105,"has_tables":true,"body_markdown":"**Item 2.03****Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.**\n\n​\n\nTo the extent applicable, the information set forth under Item 1.01 of this Current Report on Form 8-K is hereby incorporated in this Item 2.03 by reference.\n\n​\n\n2\n\n​\n\n**SIGNATURES**\n\n​\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.\n\n​\n\n**CAPRICOR THERAPEUTICS, INC.**\n\nDate: July 14, 2026\n\nBy:\n\n/s/ Linda Marbán, Ph.D.\n\nLinda Marbán, Ph.D.\n\nChief Executive Officer\n\n​\n\n​\n\n3"}